Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672574 | SCV000797688 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-02-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855580 | SCV002164860 | pathogenic | not provided | 2023-11-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr4801Phefs*20) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 556553). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003453349 | SCV004183070 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453348 | SCV004183071 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003453349 | SCV004208186 | likely pathogenic | Retinitis pigmentosa 39 | 2023-10-12 | criteria provided, single submitter | clinical testing |